| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 22.00K | — |
| Operating expense | — | — |
| Net income | -73.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLDX returned +79.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +48.7% |
| 1 year | +79.8% |
| 5 years | -23.3% |
| 10 years | -18.9% |
| All-time high | $2,340.00 (Jan 1992) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLDX would be worth today ›No. Celldex Therapeutics, Inc. has not paid a dividend in the past 12 months.
Celldex Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CLDX.
Celldex Therapeutics, Inc. is part of the Healthcare sector.
Celldex Therapeutics, Inc. has a market cap of 3.17B USD, based on the latest quote.
